C. Brihaye
About
In The Last Decade
C. Brihaye
29 papers receiving 512 citations
Peers
Comparison fields: 5 of 81
- Radiology, Nuclear Medicine and Imaging 240
- Cellular and Molecular Neuroscience 139
- Molecular Biology 133
- Pharmaceutical Science 46
- Oncology 45
Countries citing papers authored by C. Brihaye
This map shows the geographic impact of C. Brihaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Brihaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Brihaye more than expected).
Fields of papers citing papers by C. Brihaye
This network shows the impact of papers produced by C. Brihaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Brihaye. The network helps show where C. Brihaye may publish in the future.
Co-authorship network of co-authors of C. Brihaye
This figure shows the co-authorship network connecting the top 25 collaborators of C. Brihaye. A scholar is included among the top collaborators of C. Brihaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Brihaye. C. Brihaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | 38 | |
| 3 | 45 | |
| 4 | The synthesis of 6-[18F]fluoro-L-dopa by chiral catalytic phase-transfer alkylation. | 3 |
| 5 | 5-HT1A Receptors visualization with p-[18F]MPPF in healthy volunteers. | 5 |
| 6 | 115 | |
| 7 | Evaluation of p-[F-18]MPPF, 5-HT1A antagonist, in rats: tissue distribution, autoradiography and metabolism. | 2 |
| 8 | Synthesis of [18F]FDG with alkaline hydrolysis on a low polarity solid phase support. | 2 |
| 9 | Radiation dosimetry for bolus administration of oxygen-15-water. | 15 |
| 10 | Robot-assisted synthesis of [18F]altanserin, 4-[18F]fluorotropapride, 6-[18F]fluoro-L-dopa and 2-[18F]fluoro-L-tyrosine. | 3 |
| 11 | Myocardial kinetics of potassium-38 in humans and comparison with copper-62-PTSM. | 23 |
| 12 | 18 | |
| 13 | 1 | |
| 14 | 5 | |
| 15 | 9 | |
| 16 | 19 | |
| 17 | 20 | |
| 18 | Development of a reliable /sup 195m/Hg--/sup 195m/Au, generator for the production of /sup 195m/Au, a short-lived nuclide for vascular imaging | 1 |
| 19 | Development of a reliable Hg-195m--Au-195m generator for the production of Au-195m, a short-lived nuclide for vascular imaging. | 10 |
| 20 | Distribution Coefficients of Sr and Rb Ions On Various Adsorbents With a View To Achieving a Sr-rb Generator for Medical Use | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.